Top

BY Clayton R. Boldt, Ph.D.

An international consortium, led in part by clinicians and researchers from The University of Texas MD Anderson Cancer Center, has published a series of best-practice recommendations for conducting clinical trials for neoadjuvant, or pre-surgical, therapies in patients with locally advanced melanoma.

The report, published in Lancet Oncology, provides recommendations for clinical trial design, including patient inclusion criteria...

Metastatic melanoma cells

BY Clayton Boldt, Ph.D.

Leukemia researchers at The University of Texas MD Anderson Cancer Center, working collaboratively with the Therapeutics Discovery division...

BY Nicholas Almanza

Testing for BRCA1 and BRCA2 seeks to identify mutations associated with increased risk of developing certain cancers over a person’s lifetime...

BY Clayton R. Boldt, Ph.D.

Through in-depth retrospective analysis of data from more than 36,000 patients, a new study led by researchers at The University of Texas MD Anderson Cancer Center found that early-onset colorectal cancer (CRC) has distinct clinical and molecular features compared to those diagnosed later in life. Their findings were published recently in the journal CANCER.

The researchers discovered that patients with early-onset CRC, those diagnosed...

Colorectal cancer cells

BY Ron Gilmore

Whether it is new clinical trials for pediatric cancers or programs designed to increase access to smoking cessation programs for low-income...

BY Clayton R. Boldt, Ph.D.

Neoadjuvant therapy is treatment, such as chemotherapy or radiation, given before a patient has surgery. This approach is used in many cancer...

BY Clayton R. Boldt, Ph.D.

Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in adults...

BY MD Anderson staff

This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology...

BY MD Anderson staff

In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...

BY Clayton R. Boldt, Ph.D.

It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...